Intellectia LogoIntellectia
Product
Resources
Markets
News
Partner Program
Pricing
Log inTry for Free
Intellectia Logo
Log in
Intellectia Logo

Product

Features
Financial AI Agent
Stock Technical Analysis
Stock Monitor
Hedge Fund Tracker
AI Screener
Trading Strategies
AI Stock Picker
Swing Trading
Quant AI
Stock Chart Patterns
Daytrading Center
AI Earnings Prediction
Whales Auto Tracker
Backtesting Playground

Resources

Learn
Blog
Earnings
Tutorial
Help Center
Company
About Us
Contact
Press
Reward Program
Partner Program
Tools
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Compare
TradingView
SeekingAlpha

Markets

Trending Stocks
Hot Crypto
Trending News
All Stocks

News

Trading News
Overview
Top News
Daily Market Brief
Earnings
Latest
Newswire
Stock News
Crypto News
Monitor News
Partner ProgramPricing
Start for Free
  1. Home
    2. >
  2. Stock
    3. >
  3. COCH
stocks logo

COCH

-
collectAdd to Watchlistadvanced chartAdvanced Chart
$
0.000
0(0.000%)1D
collectadvanced chart
    Overview
    Forecast
    Valuation
    Earnings
High
--
Open
--
VWAP
--
Vol
--
Mkt Cap
--
Low
--
Amount
--
EV/EBITDA(TTM)
--
Total Shares
--
EV
--
EV/OCF(TTM)
--
P/S(TTM)
--
Intellectia AI SwingMax
Intellectia AI SwingMax

Market Estimates

Earnings Estimates
Earnings Estimates
Revenue
YoY Chg
EPS
YoYChg
FY2025Q4
FY2026Q1
FY2026Q2
30.00K
-28.57%
-0.240
-47.83%
45.00K
-2.17%
-0.275
-5.17%
65.00K
-16.67%
-0.310
-3.13%
Estimates Revision
The market is revising Downward the revenue expectations for Envoy Medical, Inc. (COCH) for FY2025, with the revenue forecasts being adjusted by -20% over the past three months. During the same period, the stock price has changed by -35.93%.
Revenue Estimates for FY2025
Revise Downward
down Image
-20%
In Past 3 Month
EPS Estimates for FY2025
Revise Downward
down Image
-5.56%
In Past 3 Month
Stock Price
Go Down
down Image
-35.93%
In Past 3 Month
Wall Street analysts forecast COCH stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for COCH is 5.50 USD with a low forecast of 5.00 USD and a high forecast of 6.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
2 Analyst Rating
Wall Street analysts forecast COCH stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for COCH is 5.50 USD with a low forecast of 5.00 USD and a high forecast of 6.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
2 Buy
0 Hold
0 Sell
Moderate Buy
Current: 0.846
sliders
Low
5.00
Averages
5.50
High
6.00
Current: 0.846
sliders
Low
5.00
Averages
5.50
High
6.00
Ascendiant Capital
Edward Woo
Strong Buy
Maintains
$9 → $9.25
2025-04-21
Reason
Ascendiant Capital
Edward Woo
Price Target
$9 → $9.25
2025-04-21
Maintains
Strong Buy
Reason
Ascendiant Capital
Edward Woo
Strong Buy
Maintains
$8.75 → $9
2024-12-06
Reason
Ascendiant Capital
Edward Woo
Price Target
$8.75 → $9
2024-12-06
Maintains
Strong Buy
Reason
See All Ratings

Valuation Metrics

The current forward P/E ratio for Envoy Medical Inc (COCH.O) is -0.77, compared to its 5-year average forward P/E of -1.85. For a more detailed relative valuation and DCF analysis to assess Envoy Medical Inc 's fair value, click here.
  • Forward PE
  • Forward EV/EBITDA
  • Forward PS

Forward PE

The forward P/E ratio is a valuation metric that divides a company's current stock price by its estimated future earnings per share over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
N/A
5Y Average PE
-1.85
Current PE
-0.77
Overvalued PE
-0.20
Undervalued PE
-3.51

Forward EV/EBITDA

The forward EV/EBITDA ratio is a valuation metric that divides a company's enterprise value (EV) by its estimated future earnings before interest, taxes, depreciation, and amortization (EBITDA) over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
N/A
5Y Average EV/EBITDA
-1.27
Current EV/EBITDA
0.00
Overvalued EV/EBITDA
0.79
Undervalued EV/EBITDA
-3.33

Forward PS

The forward P/S ratio is a valuation metric that divides a company's current stock price by its estimated future sales (or revenue) per share over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
N/A
5Y Average PS
105.88
Current PS
0.00
Overvalued PS
200.93
Undervalued PS
10.84
Financial AI Agent
Financial AI Agent

Financials

Annual
Quarterly
N/A
Total Revenue
N/A
Operating Profit
N/A
Net Income after Tax
N/A
EPS - Diluted
N/A
Free Cash Flow
N/A
Gross Profit Margin - %
N/A
FCF Margin - %
N/A
Net Margin - %

Trading Trends

  • Insider
  • Hedge Fund
  • Congress Trading
Insider
Insiders are Neutral. There are no significant trading trends over the last month.
Sold
Bought
Hedge Fund
Hedge Funds are Neutral. There are no significant trading trends over the last quarter.
Sold
Bought
Congress Trading
Congress are Neutral. There are no significant trading trends over the last month.
Sold
Bought
Insider
Insiders are Neutral. There are no significant trading trends over the last month.
Sold
Bought
AI Stock Picker
AI Stock Picker

COCH News & Events

Events Timeline

(ET)
2024-11-14
07:42:28
Envoy Medical reports Q3 EPS (37c) vs. 13c last year.
select
2024-11-01 (ET)
2024-11-01
08:05:27
Envoy Medical receives FDA approval to initiate study for hearing device
select
2024-10-24 (ET)
2024-10-24
08:27:06
Envoy Medical supports ITEM Coalition letter to CMS on hearing devices
select
Sign Up For More Events
Sign Up For More Events

News

[object Object]
Preview
4.0
12-04NASDAQ.COM
Envoy Medical, Inc. (COCH) Receives Upgrade to Buy: Reasons Explained

  • Zacks Rank Upgrade: Envoy Medical, Inc. has been upgraded to a Zacks Rank #2 (Buy) due to an upward trend in earnings estimates, indicating a positive outlook for the company's stock price.

  • Earnings Estimate Revisions: The Zacks rating system, which is based on earnings estimate revisions, shows a strong correlation with stock price movements, making it a valuable tool for investors.

  • Analyst Consensus: Over the past three months, the Zacks Consensus Estimate for Envoy Medical has increased by 4.3%, reflecting analysts' growing confidence in the company's earnings potential.

  • Market Positioning: The upgrade places Envoy Medical in the top 20% of Zacks-covered stocks, suggesting it is well-positioned for potential market-beating returns in the near term.

[object Object]
Preview
1.0
10-29Globenewswire
AI & Technology Virtual Investor Conference: Presentations Now Accessible for Online Viewing

  • Event Announcement: The AI & Technology Virtual Investor Conference took place on October 28, 2025, and presentations are now available for online viewing for 90 days.

  • 1x1 Meetings: Select companies are accepting one-on-one management meeting requests until November 7, 2025.

  • Participating Companies: Notable companies presenting include International Endeavors Corporation, C-COM Satellite Systems Inc., and Artificial Intelligence Technology Solutions Inc.

  • About VIC: Virtual Investor Conferences (VIC) is a platform that facilitates direct presentations from publicly traded companies to investors, enhancing engagement through interactive features.

[object Object]
Preview
1.0
10-23Globenewswire
Agenda for the AI & Technology Virtual Investor Conference Set for October 28th

  • Event Announcement: The AI & Technology Virtual Investor Conference is scheduled for October 28, 2025, hosted by Virtual Investor Conferences, inviting individual and institutional investors to participate.

  • Registration Details: Attendees are encouraged to pre-register and perform an online system check to facilitate participation, with no cost for attending live presentations or scheduling one-on-one meetings with company management.

  • Presentation Schedule: The conference will feature presentations from various companies, including Modulink Corporation, Pinewood Technologies, and C-COM Satellite Systems, among others, starting from 9:00 AM ET.

  • About Virtual Investor Conferences: VIC provides a platform for publicly traded companies to engage with investors through interactive presentations and one-on-one meetings, enhancing investor access and communication.

Sign Up For More News

People Also Watch

FAQ

arrow icon

What is Envoy Medical Inc (COCH) stock price today?

The current price of COCH is 0.8457 USD — it has increased 4.06 % in the last trading day.

arrow icon

What is Envoy Medical Inc (COCH)'s business?

Envoy Medical, Inc. is a hearing health company. The Company is engaged in providing medical technologies across the hearing loss spectrum, all designed to shift the paradigm within the hearing industry and bring both providers and patients the hearing devices they require. Its hearing solutions include hearing aids, middle ear implants, bone conduction devices and cochlear implants. The bone conduction hearing device has two components: an external component and a surgically implanted fixture placed in the bone behind the ear. Its bone conduction hearing device offers amplification without ear mold in the ear. Its hearing aids are devices that amplify sound for those with mild to moderate hearing loss. Its Esteem is a fully implanted active middle ear implant designed to improve the hearing of adults diagnosed with moderate to severe sensorineural hearing loss. Cochlear implants are a solution for people with moderate-to-profound sensorineural hearing loss.

arrow icon

What is the price predicton of COCH Stock?

Wall Street analysts forecast COCH stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for COCH is 5.50 USD with a low forecast of 5.00 USD and a high forecast of 6.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.

arrow icon

What is Envoy Medical Inc (COCH)'s revenue for the last quarter?

Envoy Medical Inc revenue for the last quarter amounts to 42.00K USD, decreased -25.00 % YoY.

arrow icon

What is Envoy Medical Inc (COCH)'s earnings per share (EPS) for the last quarter?

Envoy Medical Inc. EPS for the last quarter amounts to -0.35 USD, decreased -5.41 % YoY.

arrow icon

What changes have occurred in the market's expectations for Envoy Medical Inc (COCH)'s fundamentals?

The market is revising Downward the revenue expectations for Envoy Medical, Inc. (COCH) for FY2025, with the revenue forecasts being adjusted by -20% over the past three months. During the same period, the stock price has changed by -35.93%.
arrow icon

How many employees does Envoy Medical Inc (COCH). have?

Envoy Medical Inc (COCH) has 42 emplpoyees as of December 05 2025.

arrow icon

What is Envoy Medical Inc (COCH) market cap?

Today COCH has the market capitalization of 24.34M USD.

Intellectia LogoIntellectiaIntellectia LogoIntellectia

Redefine Your Investment Decisions

TwitterTwitterYoutubeYoutubeQuoraQuoraDiscordDiscordLinkedinLinkedinTelegramTelegram
AppStoreGooglePlay

Copyright © 2025 Intellectia.AI. All Rights Reserved.

pci certified logo
Company
HomeContactAbout UsNews Release
Compare
TradingViewSeeking Alpha
Features
Financial AI AgentStock Technical AnalysisStock MonitorHedge Fund TrackerAI ScreenerDaytrading Center
Strategies
AI Stock PickerSwing TradingStock Chart PatternsEarnings TradingDaytrading CenterAI Earnings PredictionQuant AIWhales Auto TrackerBacktesting Playground
Free Tools
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Resource
BlogTutorialEarningsTrending StocksCrypto MarketPartner ProgramTerms of UsePrivacy PolicySecuritySitemap
Start for Free